Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05225233 · ClinicalTrials.gov registry record · NA

tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity

A NA study of Obesity, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
124
Enrollment target
1
Study location

NCT05225233: Recruiting NA study of Obesity, sponsored by VA Office of Research and Development.

NCT05225233 is a NA study of Obesity that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 124 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05225233, a NA study of Obesity, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
124 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate if transcranial direct current stimulation (tDCS) can increase the effectiveness of cognitive training to reduce impulsivity in individuals with obesity, and to evaluate weight change with these individuals. The long-term goal of this research is to develop new treatment approaches for individuals with obesity.

Primary Outcome

Differences in the magnitude of change in NIH Flanker Reaction Time (RT) (ms) between active and sham groups from baseline to follow up sessions.

Conditions Studied

Interventions

  • DEVICE Sham Transcranial Direct Current Stimulation (tDCS)
  • DEVICE Active Transcranial Direct Current Stimulation (tDCS)

Study Locations (1)

Minnesota

  • Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2022-11-23
Est. Completion 2026-04-30
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT05225233 shows while recruiting

NCT05225233 is an interventional study that assigns participants to a tested intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Sham Transcranial Direct Current Stimulation (tDCS) is the first listed.

NCT05225233 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT05225233 about?

NCT05225233 is a clinical study titled "tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity". The purpose of this study is to investigate if transcranial direct current stimulation (tDCS) can increase the effectiveness of cognitive training to reduce impulsivity in individuals with obesity, and to evaluate weight change with these individuals. The long-term goal of this research is to develo...

What is the current status of trial NCT05225233?

This trial is currently recruiting. It is a NA study. The enrollment target is 124 participants. The study started on 2022-11-23. Estimated completion is 2026-04-30.

What conditions does trial NCT05225233 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT05225233?

The interventions under investigation include: Sham Transcranial Direct Current Stimulation (tDCS) (DEVICE), Active Transcranial Direct Current Stimulation (tDCS) (DEVICE).

Who is sponsoring clinical trial NCT05225233?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05225233 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05225233's enrollment target sits among peer trials

124 428th of 1053 higher than 624 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523014 · 124 participants · Phase 2

    Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

  • NCT02670707 · 124 participants · Phase 3

    Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

  • NCT02830724 · 124 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

  • NCT04748809 · 124 participants · NA

    Effect of Anti-inflammatory Diet in Rheumatoid Arthritis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05225233, the US trial registry maintained by the National Library of Medicine. NCT05225233 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.